Thorne Creatine after 50: the exact package and certification record

The current manufacturer page names Creatine — 90 Servings and identifies SKU SF903. It displays $44 for ninety scoops and offers a separate link to a 180-serving version. The ingredient section identifies creatine monohydrate, with 5 grams per labeled scoop. Those details define the record considered here. Current Thorne listing

They do not describe every flavored powder, combination or travel format that carries Thorne’s name. Keeping the package visible prevents a larger variant’s price, a flavored product’s ingredients or a stick pack’s serving description from entering this review unnoticed. The serving-and-container guide treats those distinctions as identification tasks rather than directions for use.

NSF’s current entry for Thorne Creatine describes an unflavored powder and lists 450- and 900-gram package sizes, a 5-gram scoop and specific lot identifiers. Its linked online label depicts a ninety-serving version containing creatine monohydrate. The manufacturer’s ninety-serving record and the issuer’s relevant powder record can therefore be compared on concrete fields. NSF listing and linked label

We have not matched a delivered container’s lot against that list. Nor have we treated the listing as proof of a seller’s inventory or chain of custody. A record match is narrower than verification of an item in someone’s possession, even when the brand, form and stated package information agree.

The issuer describes its program as checking label-content agreement, prohibited substances, contaminant limits and manufacturing controls. These checks address defined product-quality concerns. They are different from evidence that a person will gain strength or achieve a desired change in everyday function. NSF explanation

The third-party-testing guide also distinguishes an issuer record from a manufacturer’s own description of testing. Thorne’s page describes ingredient and finished-product testing, but this review has not audited the underlying laboratory reports. Neither the brand’s statement nor the certification mark is presented as permission to ignore a medical question or as a guarantee of zero possible risk. Manufacturer testing statements

The checked $44 figure belongs to the ninety-serving listing. It is useful as a dated observation, but no order was placed to verify taxes, delivery charges, promotion eligibility or final fulfillment. The page’s product metadata and purchase control are not substitutes for an actual transaction record. Manufacturer price

We have not imported CoreAge’s bundle discounts or Momentous’s subscription promotion into Thorne’s offer. The CoreAge review shows why that matters: a monthly equivalent on a large bundle answers a different spending question from a standalone package price. A serving count likewise does not determine how long an individual should take a supplement or whether a larger package is appropriate.

NIH’s evidence summary discusses benefits primarily in repeated bouts of high-intensity activity and describes variation in response. Those findings help explain why creatine is studied, but they do not compare this Thorne tub against Strong Suit or Momentous. NIH exercise evidence

The older-adult research guide separates study participants, exercise programs and measured outcomes. For example, the two-year postmenopausal-women trial reported different results across bone, walking and strength measures. Its abstract does not establish that a particular retail brand is the better choice for a fifty-year-old reader or for someone decades older. A product name cannot fill missing evidence about that personal goal. Primary study abstract

Thorne’s page contains its own warning and suitability language, including a recommendation to discuss individual needs with a health-care provider. That invitation does not mean the public page has already considered someone’s illnesses, medicine list or laboratory results. A favorable general statement about tolerability cannot perform that assessment either. Product questions and warnings

FDA advises informed discussion of supplements with a qualified health professional and explains the limits of premarket oversight. The clinician-question guide keeps this review from becoming a personal compatibility or kidney-clearance decision. No dose, timing, loading approach or medicine change is recommended here. FDA consumer guidance

For this version, a reader has a specific product name, a displayed price, a serving description and an issuer entry with identifiable scope. That is a useful documentary foundation. It remains separate from a supplied-lot check, a clinical explanation and a verified purchase outcome, none of which this publication has performed.

The Momentous review provides a contrasting version problem: a newly named ingredient source alongside an older issuer-linked label. Comparing that uncertainty with Thorne’s current records does not prove a difference in clinical performance. It shows why exact product details deserve attention before broad claims about quality or healthy aging are treated as settled answers.